Hyasynth Biologicals Inc.
| Booth No. | 2-038 |
|---|
| Product / Service |
Fermentation Derived CBD Isolate, Japanese Compliant Material New Products 
|
|---|---|
| Activities | Hyasynth is a sustainable biotech company that has developed and patented yeast technologies to produce THC-free, CBD ingredients made from natural sugars. Our innovative production methods provide pure and reliable cannabinoid ingredients that both brands and consumers can trust. |
| URL | https://hyasynthbio.com/ |
Presentaion
| Date | 13 October 16:30～16:50 | Location | PC |
|---|---|---|---|
| Title | The CBD Revolution: How Synthetic Biology is Creating Japan’s First Fully Complaint, Fermentation Derived CBD Isolate for Health and Wellness Products. | ||
| Detail | Cannabidiol (CBD) products are exploding in Japan with the industry experiencing nearly 100% year-over-year growth. CBD’s growing popularity is due to its multiple science-backed applications which include improving sleep, reducing pain, anxiety and inflammation. Hyasynth is using synthetic biology to make the world’s first fermentation-derived, naturally THC-free, CBD isolate. Visit our seminar to learn about the science behind CBD, Japanese regulations and how synthetic biology can make a superior CBD isolate for brands and consumers. | ||